Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Enovis Stock Quote

Enovis (NYSE: CFX)

$55.83
(1.0%)
$0.56
Price as of April 19, 2024, 4:00 p.m. ET

Enovis Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
CFX -3.48% -54.50% -14.56% +53%
S&P +20.62% +72.50% +11.51% +259%

Enovis Company Info

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.